APO Research
Talk to an analyst

APO RESEARCH · REPORT

Solid Tumors Target Proteins

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Solid Tumors Target Proteins Industry Growth and Trends Forecast to 2032

27 December 2025100 pages

Choose your research edition.

Industry ResearchSolid Tumors Target Proteins Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Solid Tumors Target Proteins Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Solid Tumors Target Proteins Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Solid Tumors Target Proteins Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Solid Tumors Target Proteins Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

According to APO Research, the global Solid Tumors Target Proteins market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Solid Tumors Target Proteins is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Solid Tumors Target Proteins is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Solid Tumors Target Proteins is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Solid Tumors Target Proteins market include Novartis, Sino Biological, ACRO Biosystems, TargetMol Chemicals, ProteoGenix, Kite Pharma, Kactus Biosystems, Juno Therapeutics and Elabscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Solid Tumors Target Proteins market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Solid Tumors Target Proteins market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Solid Tumors Target Proteins market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Solid Tumors Target Proteins.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Solid Tumors Target Proteins market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Solid Tumors Target Proteins Market by Company

Novartis

Sino Biological

ACRO Biosystems

TargetMol Chemicals

ProteoGenix

Kite Pharma

Kactus Biosystems

Juno Therapeutics

Elabscience

Creative BioMart

Creative Biolabs

Bio-Techne

Bio X Cell

ACROBiosystems

Solid Tumors Target Proteins Segment by Type

EGFR Protein

HER2 Protein

Others

Solid Tumors Target Proteins Segment by Application

Hospital

Biological Laboratory

Others

Solid Tumors Target Proteins Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Solid Tumors Target Proteins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Solid Tumors Target Proteins and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Solid Tumors Target Proteins.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Solid Tumors Target Proteins companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Solid Tumors Target Proteins Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Solid Tumors Target Proteins Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Solid Tumors Target Proteins Market Share by Region (2021-2026) Table 4. Global Solid Tumors Target Proteins Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Solid Tumors Target Proteins Market Share by Region (2027-2032) Table 6. Global Solid Tumors Target Proteins Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Solid Tumors Target Proteins Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Solid Tumors Target Proteins Market Size Share by Type (2021-2026) Table 9. Global Solid Tumors Target Proteins Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Solid Tumors Target Proteins Market Size Share Forecasted by Type (2027-2032) Table 11. North America Solid Tumors Target Proteins Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Solid Tumors Target Proteins Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Solid Tumors Target Proteins Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Solid Tumors Target Proteins Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Solid Tumors Target Proteins Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Solid Tumors Target Proteins Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Solid Tumors Target Proteins Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Solid Tumors Target Proteins Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Solid Tumors Target Proteins Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Solid Tumors Target Proteins Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Solid Tumors Target Proteins Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Solid Tumors Target Proteins Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Solid Tumors Target Proteins Market Size Share by Application (2021-2026) Table 24. Global Solid Tumors Target Proteins Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Solid Tumors Target Proteins Market Size Share Forecasted by Application (2027-2032) Table 26. North America Solid Tumors Target Proteins Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Solid Tumors Target Proteins Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Solid Tumors Target Proteins Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Solid Tumors Target Proteins Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Solid Tumors Target Proteins Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Solid Tumors Target Proteins Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Solid Tumors Target Proteins Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Solid Tumors Target Proteins Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Solid Tumors Target Proteins Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Solid Tumors Target Proteins Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Solid Tumors Target Proteins Industry Trends Table 37. Solid Tumors Target Proteins Industry Drivers Table 38. Solid Tumors Target Proteins Industry Opportunities and Challenges Table 39. Solid Tumors Target Proteins Industry Restraints Table 40. Global Solid Tumors Target Proteins Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Solid Tumors Target Proteins Revenue Market Share by Company (2021-2026) Table 42. Global Solid Tumors Target Proteins Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Solid Tumors Target Proteins Key Company Headquarters & Area Served Table 44. Global Solid Tumors Target Proteins Company, Product Type & Application Table 45. Global Solid Tumors Target Proteins Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Solid Tumors Target Proteins by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Novartis Company Information Table 49. Novartis Business Overview Table 50. Novartis Solid Tumors Target Proteins Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Novartis Solid Tumors Target Proteins Product Portfolio Table 52. Novartis Recent Development Table 53. Sino Biological Company Information Table 54. Sino Biological Business Overview Table 55. Sino Biological Solid Tumors Target Proteins Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sino Biological Solid Tumors Target Proteins Product Portfolio Table 57. Sino Biological Recent Development Table 58. ACRO Biosystems Company Information Table 59. ACRO Biosystems Business Overview Table 60. ACRO Biosystems Solid Tumors Target Proteins Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. ACRO Biosystems Solid Tumors Target Proteins Product Portfolio Table 62. ACRO Biosystems Recent Development Table 63. TargetMol Chemicals Company Information Table 64. TargetMol Chemicals Business Overview Table 65. TargetMol Chemicals Solid Tumors Target Proteins Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. TargetMol Chemicals Solid Tumors Target Proteins Product Portfolio Table 67. TargetMol Chemicals Recent Development Table 68. ProteoGenix Company Information Table 69. ProteoGenix Business Overview Table 70. ProteoGenix Solid Tumors Target Proteins Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. ProteoGenix Solid Tumors Target Proteins Product Portfolio Table 72. ProteoGenix Recent Development Table 73. Kite Pharma Company Information Table 74. Kite Pharma Business Overview Table 75. Kite Pharma Solid Tumors Target Proteins Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Kite Pharma Solid Tumors Target Proteins Product Portfolio Table 77. Kite Pharma Recent Development Table 78. Kactus Biosystems Company Information Table 79. Kactus Biosystems Business Overview Table 80. Kactus Biosystems Solid Tumors Target Proteins Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Kactus Biosystems Solid Tumors Target Proteins Product Portfolio Table 82. Kactus Biosystems Recent Development Table 83. Juno Therapeutics Company Information Table 84. Juno Therapeutics Business Overview Table 85. Juno Therapeutics Solid Tumors Target Proteins Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Juno Therapeutics Solid Tumors Target Proteins Product Portfolio Table 87. Juno Therapeutics Recent Development Table 88. Elabscience Company Information Table 89. Elabscience Business Overview Table 90. Elabscience Solid Tumors Target Proteins Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Elabscience Solid Tumors Target Proteins Product Portfolio Table 92. Elabscience Recent Development Table 93. Creative BioMart Company Information Table 94. Creative BioMart Business Overview Table 95. Creative BioMart Solid Tumors Target Proteins Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Creative BioMart Solid Tumors Target Proteins Product Portfolio Table 97. Creative BioMart Recent Development Table 98. Creative Biolabs Company Information Table 99. Creative Biolabs Business Overview Table 100. Creative Biolabs Solid Tumors Target Proteins Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Creative Biolabs Solid Tumors Target Proteins Product Portfolio Table 102. Creative Biolabs Recent Development Table 103. Bio-Techne Company Information Table 104. Bio-Techne Business Overview Table 105. Bio-Techne Solid Tumors Target Proteins Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Bio-Techne Solid Tumors Target Proteins Product Portfolio Table 107. Bio-Techne Recent Development Table 108. Bio X Cell Company Information Table 109. Bio X Cell Business Overview Table 110. Bio X Cell Solid Tumors Target Proteins Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Bio X Cell Solid Tumors Target Proteins Product Portfolio Table 112. Bio X Cell Recent Development Table 113. ACROBiosystems Company Information Table 114. ACROBiosystems Business Overview Table 115. ACROBiosystems Solid Tumors Target Proteins Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. ACROBiosystems Solid Tumors Target Proteins Product Portfolio Table 117. ACROBiosystems Recent Development Table 118. North America Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Solid Tumors Target Proteins Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Solid Tumors Target Proteins Market Share by Country (2021-2026) Table 121. North America Solid Tumors Target Proteins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Solid Tumors Target Proteins Market Share Forecast by Country (2027-2032) Table 123. Europe Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Solid Tumors Target Proteins Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Solid Tumors Target Proteins Market Share by Country (2021-2026) Table 126. Europe Solid Tumors Target Proteins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Solid Tumors Target Proteins Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Solid Tumors Target Proteins Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Solid Tumors Target Proteins Market Share by Country (2021-2026) Table 131. Asia-Pacific Solid Tumors Target Proteins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Solid Tumors Target Proteins Market Share Forecast by Country (2027-2032) Table 133. Latin America Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Solid Tumors Target Proteins Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Solid Tumors Target Proteins Market Share by Country (2021-2026) Table 136. Latin America Solid Tumors Target Proteins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Solid Tumors Target Proteins Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa Solid Tumors Target Proteins Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa Solid Tumors Target Proteins Market Share by Country (2021-2026) Table 141. Middle East & Africa Solid Tumors Target Proteins Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa Solid Tumors Target Proteins Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Solid Tumors Target Proteins Product Image Figure 3. Global Solid Tumors Target Proteins Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Solid Tumors Target Proteins Market Size (2021-2032) & (US$ Million) Figure 5. Global Solid Tumors Target Proteins Market Share by Region: 2025 VS 2032 Figure 6. Global Solid Tumors Target Proteins Market Share by Region (2021-2032) Figure 7. North America Solid Tumors Target Proteins Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Solid Tumors Target Proteins Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Solid Tumors Target Proteins Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Solid Tumors Target Proteins Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Solid Tumors Target Proteins Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. EGFR Protein Image Figure 13. Global EGFR Protein Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. HER2 Protein Image Figure 15. Global HER2 Protein Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Others Image Figure 17. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Solid Tumors Target Proteins Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Solid Tumors Target Proteins Market Share by Type 2025 VS 2032 Figure 20. North America Solid Tumors Target Proteins Market Size Share by Type (2021-2032) Figure 21. Europe Solid Tumors Target Proteins Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Solid Tumors Target Proteins Market Size Share by Type (2021-2032) Figure 23. Latin America Solid Tumors Target Proteins Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Solid Tumors Target Proteins Market Size Share by Type (2021-2032) Figure 25. Hospital Image Figure 26. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Biological Laboratory Image Figure 28. Global Biological Laboratory Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Solid Tumors Target Proteins Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Solid Tumors Target Proteins Market Share by Application 2025 VS 2032 Figure 33. North America Solid Tumors Target Proteins Market Size Share by Application (2021-2032) Figure 34. Europe Solid Tumors Target Proteins Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Solid Tumors Target Proteins Market Size Share by Application (2021-2032) Figure 36. Latin America Solid Tumors Target Proteins Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Solid Tumors Target Proteins Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Solid Tumors Target Proteins Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Solid Tumors Target Proteins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Solid Tumors Target Proteins Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Solid Tumors Target Proteins Market Share by Country (2021-2032) Figure 43. Europe Solid Tumors Target Proteins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Solid Tumors Target Proteins Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Solid Tumors Target Proteins Market Share by Country (2021-2032) Figure 46. Asia-Pacific Solid Tumors Target Proteins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Solid Tumors Target Proteins Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Solid Tumors Target Proteins Market Share by Country (2021-2032) Figure 49. Latin America Solid Tumors Target Proteins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Solid Tumors Target Proteins Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Solid Tumors Target Proteins Market Share by Country (2021-2032) Figure 52. Middle East & Africa Solid Tumors Target Proteins Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Solid Tumors Target Proteins Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Solid Tumors Target Proteins Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • EGFR Protein
  • HER2 Protein
  • Others
Applications
  • Hospital
  • Biological Laboratory
  • Others
Companies covered
  • Novartis
  • Sino Biological
  • ACRO Biosystems
  • TargetMol Chemicals
  • ProteoGenix
  • Kite Pharma
  • Kactus Biosystems
  • Juno Therapeutics
  • Elabscience
  • Creative BioMart
  • Creative Biolabs
  • Bio-Techne
  • Bio X Cell
  • ACROBiosystems

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Solid Tumors Target Proteins Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Solid Tumors Target Proteins Market Size by Region (2021-2032)
  5. 1.4.1 Global Solid Tumors Target Proteins Market Size by Region (2021-2026)
  6. 1.4.2 Global Solid Tumors Target Proteins Market Size by Region (2027-2032)
  7. 1.5 Key Regions Solid Tumors Target Proteins Market Size (2021-2032)
  8. 1.5.1 North America Solid Tumors Target Proteins Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Solid Tumors Target Proteins Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Solid Tumors Target Proteins Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Solid Tumors Target Proteins Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Solid Tumors Target Proteins Market Size Growth Rate (2021-2032)
2 Solid Tumors Target Proteins Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 EGFR Protein
  3. 2.1.2 HER2 Protein
  4. 2.1.3 Others
  5. 2.2 Global Solid Tumors Target Proteins Market Size by Type
  6. 2.2.1 Global Solid Tumors Target Proteins Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Solid Tumors Target Proteins Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Solid Tumors Target Proteins Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Solid Tumors Target Proteins Market Size by Regions
  10. 2.3.1 North America Solid Tumors Target Proteins Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Solid Tumors Target Proteins Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Solid Tumors Target Proteins Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Solid Tumors Target Proteins Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Solid Tumors Target Proteins Market Size Breakdown by Type (2021-2026)
3 Solid Tumors Target Proteins Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Biological Laboratory
  4. 3.1.3 Others
  5. 3.2 Global Solid Tumors Target Proteins Market Size by Application
  6. 3.2.1 Global Solid Tumors Target Proteins Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Solid Tumors Target Proteins Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Solid Tumors Target Proteins Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Solid Tumors Target Proteins Market Size by Regions
  10. 3.3.1 North America Solid Tumors Target Proteins Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Solid Tumors Target Proteins Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Solid Tumors Target Proteins Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Solid Tumors Target Proteins Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Solid Tumors Target Proteins Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Solid Tumors Target Proteins Industry Trends
  2. 4.2 Solid Tumors Target Proteins Industry Drivers
  3. 4.3 Solid Tumors Target Proteins Industry Opportunities and Challenges
  4. 4.4 Solid Tumors Target Proteins Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Solid Tumors Target Proteins Revenue (2021-2026)
  2. 5.2 Global Solid Tumors Target Proteins Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Solid Tumors Target Proteins Key Company Headquarters & Area Served
  4. 5.4 Global Solid Tumors Target Proteins Company, Product Type & Application
  5. 5.5 Global Solid Tumors Target Proteins Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Solid Tumors Target Proteins Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Solid Tumors Target Proteins Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Solid Tumors Target Proteins Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Solid Tumors Target Proteins Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Sino Biological
  8. 6.2.1 Sino Biological Company Information
  9. 6.2.2 Sino Biological Business Overview
  10. 6.2.3 Sino Biological Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sino Biological Solid Tumors Target Proteins Product Portfolio
  12. 6.2.5 Sino Biological Recent Developments
  13. 6.3 ACRO Biosystems
  14. 6.3.1 ACRO Biosystems Company Information
  15. 6.3.2 ACRO Biosystems Business Overview
  16. 6.3.3 ACRO Biosystems Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 ACRO Biosystems Solid Tumors Target Proteins Product Portfolio
  18. 6.3.5 ACRO Biosystems Recent Developments
  19. 6.4 TargetMol Chemicals
  20. 6.4.1 TargetMol Chemicals Company Information
  21. 6.4.2 TargetMol Chemicals Business Overview
  22. 6.4.3 TargetMol Chemicals Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 TargetMol Chemicals Solid Tumors Target Proteins Product Portfolio
  24. 6.4.5 TargetMol Chemicals Recent Developments
  25. 6.5 ProteoGenix
  26. 6.5.1 ProteoGenix Company Information
  27. 6.5.2 ProteoGenix Business Overview
  28. 6.5.3 ProteoGenix Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 ProteoGenix Solid Tumors Target Proteins Product Portfolio
  30. 6.5.5 ProteoGenix Recent Developments
  31. 6.6 Kite Pharma
  32. 6.6.1 Kite Pharma Company Information
  33. 6.6.2 Kite Pharma Business Overview
  34. 6.6.3 Kite Pharma Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Kite Pharma Solid Tumors Target Proteins Product Portfolio
  36. 6.6.5 Kite Pharma Recent Developments
  37. 6.7 Kactus Biosystems
  38. 6.7.1 Kactus Biosystems Company Information
  39. 6.7.2 Kactus Biosystems Business Overview
  40. 6.7.3 Kactus Biosystems Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Kactus Biosystems Solid Tumors Target Proteins Product Portfolio
  42. 6.7.5 Kactus Biosystems Recent Developments
  43. 6.8 Juno Therapeutics
  44. 6.8.1 Juno Therapeutics Company Information
  45. 6.8.2 Juno Therapeutics Business Overview
  46. 6.8.3 Juno Therapeutics Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Juno Therapeutics Solid Tumors Target Proteins Product Portfolio
  48. 6.8.5 Juno Therapeutics Recent Developments
  49. 6.9 Elabscience
  50. 6.9.1 Elabscience Company Information
  51. 6.9.2 Elabscience Business Overview
  52. 6.9.3 Elabscience Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Elabscience Solid Tumors Target Proteins Product Portfolio
  54. 6.9.5 Elabscience Recent Developments
  55. 6.10 Creative BioMart
  56. 6.10.1 Creative BioMart Company Information
  57. 6.10.2 Creative BioMart Business Overview
  58. 6.10.3 Creative BioMart Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Creative BioMart Solid Tumors Target Proteins Product Portfolio
  60. 6.10.5 Creative BioMart Recent Developments
  61. 6.11 Creative Biolabs
  62. 6.11.1 Creative Biolabs Company Information
  63. 6.11.2 Creative Biolabs Business Overview
  64. 6.11.3 Creative Biolabs Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Creative Biolabs Solid Tumors Target Proteins Product Portfolio
  66. 6.11.5 Creative Biolabs Recent Developments
  67. 6.12 Bio-Techne
  68. 6.12.1 Bio-Techne Company Information
  69. 6.12.2 Bio-Techne Business Overview
  70. 6.12.3 Bio-Techne Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Bio-Techne Solid Tumors Target Proteins Product Portfolio
  72. 6.12.5 Bio-Techne Recent Developments
  73. 6.13 Bio X Cell
  74. 6.13.1 Bio X Cell Company Information
  75. 6.13.2 Bio X Cell Business Overview
  76. 6.13.3 Bio X Cell Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Bio X Cell Solid Tumors Target Proteins Product Portfolio
  78. 6.13.5 Bio X Cell Recent Developments
  79. 6.14 ACROBiosystems
  80. 6.14.1 ACROBiosystems Company Information
  81. 6.14.2 ACROBiosystems Business Overview
  82. 6.14.3 ACROBiosystems Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 ACROBiosystems Solid Tumors Target Proteins Product Portfolio
  84. 6.14.5 ACROBiosystems Recent Developments
7 North America
  1. 7.1 North America Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Solid Tumors Target Proteins Market Size by Country (2021-2026)
  3. 7.3 North America Solid Tumors Target Proteins Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Solid Tumors Target Proteins Market Size by Country (2021-2026)
  3. 8.3 Europe Solid Tumors Target Proteins Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Solid Tumors Target Proteins Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Solid Tumors Target Proteins Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Solid Tumors Target Proteins Market Size by Country (2021-2026)
  3. 10.3 South America Solid Tumors Target Proteins Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Solid Tumors Target Proteins Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Solid Tumors Target Proteins Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst